Clinical Trial Update: Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety comparison of BCD-055 and Remicade (infliximab) in patients with ankylosing spondylitis. The trial is completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• BCD-055 (infliximab biosimilar)
• Remicade (infliximab)

Snippet

Sponsor: Biocad | Conditions: Ankylosing Spondylitis | Phase 1 | Status: COMPLETED | Results posted: 2016-06-08